Queens New York Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• County: Queens
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages Keywords: Queens New York, Collateral License Agreement, Gentling, Inc., University of North Texas Health Science Center Title: Queens New York Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center Introduction: The Queens New York Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding agreement that outlines the terms and conditions regarding the licensing of collateral, intellectual property, and other assets between the parties involved. This agreement is crucial in fostering collaborative research and development efforts, as well as protecting the interests of both parties. Types of Collateral License Agreements: 1. Technology Licensing Agreement: This type of Collateral License Agreement focuses on the licensing of technology-related collateral, such as patents, trademarks, software, and other intellectual property developed by either Gentling, Inc. or The University of North Texas Health Science Center. It ensures the proper utilization and protection of these assets, enabling innovative solutions and commercialization efforts. 2. Research Collaboration Agreement: This Collateral License Agreement emphasizes the collaboration between Gentling, Inc. and The University of North Texas Health Science Center on various research projects. It establishes clear guidelines for intellectual property ownership, publication rights, and financial obligations, allowing both parties to benefit from joint research initiatives. 3. Exclusive License Agreement: An Exclusive License Agreement grants Gentling, Inc. exclusive rights to use the licensed collateral developed by The University of North Texas Health Science Center in the designated field. This type of agreement allows Gentling, Inc. to gain a competitive advantage in the market by restricting the licensing of those assets to other entities. Key Provisions of the Agreement: 1. Grant of License: This section outlines the specific collateral, intellectual property, or assets being licensed and the scope of rights granted to Gentling, Inc. by The University of North Texas Health Science Center. 2. Financial Considerations: The financial terms and conditions, including upfront fees, royalties, milestone payments, and revenue sharing, are detailed in this section. Both parties agree on the monetary compensation related to the licensed collateral. 3. Intellectual Property Rights: This provision addresses the ownership and protection of intellectual property developed during the collaboration. It clarifies the ownership rights and governs how the parties should handle patent applications, copyrights, and trade secrets. 4. Confidentiality and Non-Disclosure: This section ensures that all confidential information exchanged during the collaboration remains strictly confidential. It binds both parties to maintain the confidentiality of trade secrets, research data, and proprietary information. 5. Termination and Dispute Resolution: The terms and conditions for terminating the agreement, as well as the process for resolving any disputes that may arise, are outlined in this section. It aims to ensure a fair and amicable resolution to any conflicts that may arise during the collaboration. Conclusion: The Queens New York Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center signifies a valuable partnership in research, development, and commercialization efforts. With various types of license agreements available, both parties can foster innovation, protect their interests, and contribute to the advancement of scientific knowledge and technology.

Keywords: Queens New York, Collateral License Agreement, Gentling, Inc., University of North Texas Health Science Center Title: Queens New York Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center Introduction: The Queens New York Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding agreement that outlines the terms and conditions regarding the licensing of collateral, intellectual property, and other assets between the parties involved. This agreement is crucial in fostering collaborative research and development efforts, as well as protecting the interests of both parties. Types of Collateral License Agreements: 1. Technology Licensing Agreement: This type of Collateral License Agreement focuses on the licensing of technology-related collateral, such as patents, trademarks, software, and other intellectual property developed by either Gentling, Inc. or The University of North Texas Health Science Center. It ensures the proper utilization and protection of these assets, enabling innovative solutions and commercialization efforts. 2. Research Collaboration Agreement: This Collateral License Agreement emphasizes the collaboration between Gentling, Inc. and The University of North Texas Health Science Center on various research projects. It establishes clear guidelines for intellectual property ownership, publication rights, and financial obligations, allowing both parties to benefit from joint research initiatives. 3. Exclusive License Agreement: An Exclusive License Agreement grants Gentling, Inc. exclusive rights to use the licensed collateral developed by The University of North Texas Health Science Center in the designated field. This type of agreement allows Gentling, Inc. to gain a competitive advantage in the market by restricting the licensing of those assets to other entities. Key Provisions of the Agreement: 1. Grant of License: This section outlines the specific collateral, intellectual property, or assets being licensed and the scope of rights granted to Gentling, Inc. by The University of North Texas Health Science Center. 2. Financial Considerations: The financial terms and conditions, including upfront fees, royalties, milestone payments, and revenue sharing, are detailed in this section. Both parties agree on the monetary compensation related to the licensed collateral. 3. Intellectual Property Rights: This provision addresses the ownership and protection of intellectual property developed during the collaboration. It clarifies the ownership rights and governs how the parties should handle patent applications, copyrights, and trade secrets. 4. Confidentiality and Non-Disclosure: This section ensures that all confidential information exchanged during the collaboration remains strictly confidential. It binds both parties to maintain the confidentiality of trade secrets, research data, and proprietary information. 5. Termination and Dispute Resolution: The terms and conditions for terminating the agreement, as well as the process for resolving any disputes that may arise, are outlined in this section. It aims to ensure a fair and amicable resolution to any conflicts that may arise during the collaboration. Conclusion: The Queens New York Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center signifies a valuable partnership in research, development, and commercialization efforts. With various types of license agreements available, both parties can foster innovation, protect their interests, and contribute to the advancement of scientific knowledge and technology.